RiboX Therapeutics Announces FDA Clearance for IND Application of RXRG001, the First Circular RNA Therapy for the Treatment of Radiation-Induced Xerostomia and Hyposalivation
PRINCETON,N.J.,Oct. 26,2024-- RiboX Therapeutics Ltd. (RiboX),a pioneering biopharmaceutical company,focused on discovering and developing fully engineered circular RNA therapeutics,announced that the